Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial)

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

John J.V. McMurray, Stamatis Adamopoulos, Stefan D. Anker et al. · European Heart Journal · 2012 · 6.9K citations · Full text

Medicine, Cardiology, Internal Medicine +12

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina et al. · EP Europace · 2012 · 3.8K citations · Full text

Medicine, Cardiology, Internal Medicine +17

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Valentı́n Fuster, Lars Rydén, D.S. Cannom et al. · Journal of the American College of Cardiology · 2011 · 929 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15

Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human Plasma

Nils G. Morgenthaler, Joachim Struck, Barbara Thomas et al. · Clinical Chemistry · 2004 · 337 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)

Sune Darkner, X. Chen, Jim Hansen et al. · European Heart Journal · 2014 · 141 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12